Gastroesophageal Adenocarcinoma Active Not Recruiting Phase 2 Trials for Cabazitaxel (DB06772)

IndicationStatusPhase
DBCOND0030813 (Gastroesophageal Adenocarcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01757171Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal AdenocarcinomaTreatment